5. Application of Japanese Claims Database to Pharmacovigilance Activity in Pharmaceutical Industry; Analysis on Cancer Incidences and Usage of Anticancer Agents-Reference-Cited by-同舟云学术

5. Application of Japanese Claims Database to Pharmacovigilance Activity in Pharmaceutical Industry; Analysis on Cancer Incidences and Usage of Anticancer Agents

Published:2013 Issue:2 Volume:17 Page:145-153
ISSN:1342-0445
Container-title:Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku
language:en
Short-container-title:Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku

Author:

HAMADA Kenji,AOKI Kotonari

Publisher

Japanese Society for Pharmacoepidemiology

Subject

General Medicine

Reference11 articles.

1. 2) Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T; Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan(MCIJ) project. Jpn J Clin Oncol. 2012 Feb; 42: 139-47.［http://ganjoho.jp/professional/statistics/statistics.html#04］

2. 4) Robert C, Soria JC, Spatz A, et al. Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol. 2005 Jul; 6(7): 491-500. Review.

3. 5) Pérez-Soler R, Delord JP, Halpern A, et al. HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum. Oncologist. 2005 May; 10(5): 345-56.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inventory of real‐world data sources in Japan: Annual survey conducted by the Japanese Society for Pharmacoepidemiology Task Force;Pharmacoepidemiology and Drug Safety;2023-08-31

2. Prevalence, incidence, and medications of narcolepsy in Japan: a descriptive observational study using a health insurance claims database;Sleep and Biological Rhythms;2022-08-30

3. Preface;Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku;2022-06-25